» Articles » PMID: 31952509

The Progress of Gut Microbiome Research Related to Brain Disorders

Overview
Publisher Biomed Central
Date 2020 Jan 19
PMID 31952509
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

There is increasing evidence showing that the dynamic changes in the gut microbiota can alter brain physiology and behavior. Cognition was originally thought to be regulated only by the central nervous system. However, it is now becoming clear that many non-nervous system factors, including the gut-resident bacteria of the gastrointestinal tract, regulate and influence cognitive dysfunction as well as the process of neurodegeneration and cerebrovascular diseases. Extrinsic and intrinsic factors including dietary habits can regulate the composition of the microbiota. Microbes release metabolites and microbiota-derived molecules to further trigger host-derived cytokines and inflammation in the central nervous system, which contribute greatly to the pathogenesis of host brain disorders such as pain, depression, anxiety, autism, Alzheimer's diseases, Parkinson's disease, and stroke. Change of blood-brain barrier permeability, brain vascular physiology, and brain structure are among the most critical causes of the development of downstream neurological dysfunction. In this review, we will discuss the following parts: Overview of technical approaches used in gut microbiome studiesMicrobiota and immunityGut microbiota and metabolitesMicrobiota-induced blood-brain barrier dysfunctionNeuropsychiatric diseases ■ Stress and depression■ Pain and migraine■ Autism spectrum disordersNeurodegenerative diseases ■ Parkinson's disease■ Alzheimer's disease■ Amyotrophic lateral sclerosis■ Multiple sclerosisCerebrovascular disease ■ Atherosclerosis■ Stroke■ Arteriovenous malformationConclusions and perspectives.

Citing Articles

Bacteria invade the brain following intracortical microelectrode implantation, inducing gut-brain axis disruption and contributing to reduced microelectrode performance.

Hoeferlin G, Grabinski S, Druschel L, Duncan J, Burkhart G, Weagraff G Nat Commun. 2025; 16(1):1829.

PMID: 39979293 PMC: 11842729. DOI: 10.1038/s41467-025-56979-4.


Photobiomodulation of gut microbiota with low-level laser therapy: a light for treating neuroinflammation.

da Silva L, Martins D, de Oliveira M, Stenier M, Fernandes B, Willemann S Lasers Med Sci. 2025; 40(1):64.

PMID: 39903307 DOI: 10.1007/s10103-025-04319-9.


Relationship Between Depression and Epigallocatechin Gallate from the Perspective of Gut Microbiota: A Systematic Review.

Zhang Y, Liu C, Zhu Q, Wu H, Liu Z, Zeng L Nutrients. 2025; 17(2).

PMID: 39861389 PMC: 11767295. DOI: 10.3390/nu17020259.


Age-Related Changes in Gut Health and Behavioral Biomarkers in a Beagle Dog Population.

Fernandez-Pinteno A, Pilla R, Suchodolski J, Apper E, Torre C, Salas-Mani A Animals (Basel). 2025; 15(2).

PMID: 39858234 PMC: 11758293. DOI: 10.3390/ani15020234.


Influential articles in autism and gut microbiota: bibliometric profile and research trends.

Ying J, Zhang M, Wei K, Wong S, Subramaniam M Front Microbiol. 2025; 15():1401597.

PMID: 39850141 PMC: 11755156. DOI: 10.3389/fmicb.2024.1401597.


References
1.
Shechter R, Ronen A, Rolls A, London A, Bakalash S, Young M . Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol. 2008; 183(3):393-400. PMC: 2575781. DOI: 10.1083/jcb.200804010. View

2.
Schroeder J, Dinatale B, Murray I, Flaveny C, Liu Q, Laurenzana E . The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry. 2009; 49(2):393-400. PMC: 2805781. DOI: 10.1021/bi901786x. View

3.
Rerksuppaphol S, Rerksuppaphol L . A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia. J Clin Diagn Res. 2015; 9(3):KC01-4. PMC: 4413085. DOI: 10.7860/JCDR/2015/11867.5728. View

4.
Faraji F, Zarinfar N, Zanjani A, Morteza A . The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. Pain Physician. 2012; 15(6):495-8. View

5.
Su J, Zhou X, Zhang G . Association between Helicobacter pylori infection and migraine: a meta-analysis. World J Gastroenterol. 2014; 20(40):14965-72. PMC: 4209561. DOI: 10.3748/wjg.v20.i40.14965. View